CD8A and neoplasm: Clinical studies have demonstrated that IL-7 plays a pivotal role in enhancing the proliferation, survival, and functional competence of both CD4+ helper T cells and CD8+ cytotoxic T lymphocytes—key effector subsets that orchestrate adaptive anti-tumor immune responses [36].